Delco F - Search Results

1

Postprandial control of gallbladder contraction and exocrine pancreatic secretion in man.

Beglinger C, Hildebrand P, Adler G, Werth B, Luo H, Delco F, Gyr K. Beglinger C, et al. Among authors: delco f. Eur J Clin Invest. 1992 Dec;22(12):827-34. doi: 10.1111/j.1365-2362.1992.tb01453.x. Eur J Clin Invest. 1992. PMID: 1282465 Clinical Trial.

2

A physiological role for cholecystokinin as a regulator of gastrin secretion.

Beglinger C, Hildebrand P, Meier R, Bauerfeind P, Hasslocher H, Urscheler N, Delco F, Eberle A, Gyr K. Beglinger C, et al. Among authors: delco f. Gastroenterology. 1992 Aug;103(2):490-5. doi: 10.1016/0016-5085(92)90838-p. Gastroenterology. 1992. PMID: 1634067

3

Human gastrin-releasing peptide: biological potency in humans.

Hildebrand P, Werth B, Beglinger C, Delco F, Jansen JB, Lamers CB, Gyr K. Hildebrand P, et al. Among authors: delco f. Regul Pept. 1991 Nov 26;36(3):423-33. doi: 10.1016/0167-0115(91)90075-r. Regul Pept. 1991. PMID: 1811276

4

Effect of a cholecystokinin antagonist on meal-stimulated insulin and pancreatic polypeptide release in humans.

Hildebrand P, Ensinck JW, Ketterer S, Delco F, Mossi S, Bangerter U, Beglinger C. Hildebrand P, et al. Among authors: delco f. J Clin Endocrinol Metab. 1991 May;72(5):1123-9. doi: 10.1210/jcem-72-5-1123. J Clin Endocrinol Metab. 1991. PMID: 2022712 Clinical Trial.

5

Cholecystokinin is a physiological regulator of gastric acid secretion in man.

Burckhardt B, Delco F, Ensinck JW, Meier R, Bauerfeind P, Aufderhaar U, Ketterer S, Gyr K, Beglinger C. Burckhardt B, et al. Among authors: delco f. Eur J Clin Invest. 1994 Jun;24(6):370-6. doi: 10.1111/j.1365-2362.1994.tb02178.x. Eur J Clin Invest. 1994. PMID: 7957488 Clinical Trial.

6

Effect of intravenous infusions of thiamine on the disposition kinetics of thiamine and its pyrophosphate.

Drewe J, Delco F, Kissel T, Beglinger C. Drewe J, et al. Among authors: delco f. J Clin Pharm Ther. 2003 Feb;28(1):47-51. doi: 10.1046/j.1365-2710.2003.00462.x. J Clin Pharm Ther. 2003. PMID: 12605618 Clinical Trial.

7

Hospital health care resource utilization and costs of colorectal cancer during the first 3-year period following diagnosis in Switzerland.

Delcò F, Egger R, Bauerfeind P, Beglinger C. Delcò F, et al. Aliment Pharmacol Ther. 2005 Mar 1;21(5):615-22. doi: 10.1111/j.1365-2036.2005.02362.x. Aliment Pharmacol Ther. 2005. PMID: 15740546

8

Health care resource utilization and costs of NSAID-induced gastrointestinal toxicity. A population-based study in Switzerland.

Delcò F, Michetti P, Beglinger C, Fried M, Szucs TD. Delcò F, et al. Digestion. 2004;69(1):10-9. doi: 10.1159/000076542. Epub 2004 Jan 30. Digestion. 2004. PMID: 14755148

9

Dose adjustment in patients with liver disease.

Delcò F, Tchambaz L, Schlienger R, Drewe J, Krähenbühl S. Delcò F, et al. Drug Saf. 2005;28(6):529-45. doi: 10.2165/00002018-200528060-00005. Drug Saf. 2005. PMID: 15924505 Review.

10

Is virtual colonoscopy a cost-effective option to screen for colorectal cancer?

Sonnenberg A, Delcò F, Bauerfeind P. Sonnenberg A, et al. Among authors: delco f. Am J Gastroenterol. 1999 Aug;94(8):2268-74. doi: 10.1111/j.1572-0241.1999.01304.x. Am J Gastroenterol. 1999. PMID: 10445561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters